THE European Medicines Agency has moved to the next stage of its momentous relocation from London to Amsterdam, with the move forced by Britain's imminent exit from the European Union.
EMA left its former London office on 01 Mar, and staff will gradually move in the coming days into the Spark building in the Amsterdam Sloterdijk district.
The temporary arrangements will see the EMA operate from the Spark building until its new tailor-made premises in Amsterdam Zuidas become available.
By next Mon about 350 staff will be settled in the new office, while a number of EMA employees will work remotely from London before moving to Amsterdam later in 2019.
Overall the agency still anticipates losing about 25% of its total 900-strong workforce as a result of the switch from the UK
The above article was sent to subscribers in Pharmacy Daily's issue from 13 Mar 19
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 13 Mar 19
